Trends in cervical cancer survival in Europe, 1983-1994: A population-based study

Gynecologic Oncology

Volumn 105, Issue 3, 2007, Pages 609-619

  Bielska Lasota, Magdalena ^a   Inghelmann, Riccardo ^b   van de Poll Franse, Lonneke ^c   Oberaigner, W ^d   Storm, H H ^e   Aareleid, T ^f   Jechova, M ^g   Rousarova, M ^g   Hakulinen, T ^h   Hedelin G ⁱ   Tron, I ^j   Le Gall, E ^j   Launoy, G ^k   Mace Lesec'h J ^l   Faivre, J ^m   Chaplain, G ⁿ   Carli, P M ^o   Danzon, A ^p   Tretarre, B ^q   Colonna, M ^r   Lacour, B ^s   Raverdy, N ^t   Berger, C ^u   Freycon, B ^u   Grosclaude, P ^v   Esteve J ^w   Kaatsch, P ^x   Ziegler, H ^y   Holzel D ^z   Schubert Fritschle, G ^z   Tryggvadottir, L ^aa   Berrino, F ^ab   Allemani, C ^ac   Baili, P ^ac   Ciccolallo, L ^ac   Crosignani, P ^ac   Gatta, G ^ac   Micheli, A ^ac   Sant, M ^ac   Taussig, E ^ac   Sowe, S ^ac   Ferretti, S ^ad   Conti, E ^ae   Vercelli, M ^af   Quaglia, A ^af   Pannelli, F ^ag   Federico, M ^ah   Artioli, M E ^ah   Ponz De Leon, M ^ai   Benatti, P ^ai   De Lisi, V ^aj   Servente, L ^aj   Zanetti, R ^ak   Patriarca, S ^ak   Magnani, C ^al   Pastore, G ^al   Gafa L ^am   Tumino, R ^am   Falcini, F ^an   Budroni, M ^ao   Paci, E ^ap   Crocetti, E ^ap   Zambon, P ^aq   Guzzinati, S ^aq   Capocaccia, R ^ar   Carrani, E ^ar   De Angelis, R ^ar   Roazzi, P ^ar   Santaquilani, M ^ar   Tavilla, A ^ar   Valente, F ^ar   Verdecchia, A ^ar   Dalmas, M ^as   Langmark, F ^at   Andersen, A ^at   Pinheiro, P ^au   Rachtan, J ^av   Bielska Lasota, M ^a   Wronkowski, Z ^a   Zwierko, M ^a   Plesko I ^aw   Obsitnikova A ^aw   Pompe Kirn, V ^ax   Primic Zakelj M ^ax   Izarzugaza, I ^ay   Martinez Garcia, C ^az   Garau, I ^ba   Navarro, C ^bb   Chirlaque, M D ^bb   Ardanaz, E ^bc   Moreno, C ^bc   Galceran, J ^bd   Torrella, A ^be   Peris Bonet, R ^bf   Barlow, L ^bg   Moller T ^bh   Jundt, G ^bi   Lutz, J M ^bj   Bouchardy, C ^bj   Coebergh, J W W ^c   van der Does van den Berg, A ^bk   Visser, O ^bl   Godward, S ^bm   Coleman, M P ^bn   Williams, E M I ^bo   Forman, D ^bp   Quinn, M J ^bq   Roche, M ^br   Edwards, S ^br   Stiller, C ^bs   Verne, J ^ab   Moller H ^bt   Bell, J ^bt   Botha, H ^bu   Lawrence, G ^bv   Black, R ^bw   Steward, J A ^bx   more..

^a INSTITUTE OF ONCOLOGY   (Poland)

^b National Centre of Epidemiology   (Italy)

^c Eindhoven Cancer Registry   (Netherlands)

^d Tyrol Cancer Registry   (Austria)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f Estonian Cancer Registry   (Estonia)

^g IHIS and West Bohemia Cancer Registry   (Czech Republic)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ Cancer Registry of Bas Rhin   (France)

^j Bretagne Childhood Cancer Registry   (France)

^k Calvados Digestive Cancer Registry   (France)

^l Calvados General Cancer Registry   (France)

^m Côte d' or Digestive Cancer Registry   (France)

ⁿ Côte d'Or Gynaecological Cancer Registry   (France)

^o ote d'Or Malignant Haemopathies Registry   (France)

^p Doubs Cancer Registry   (France)

^q Herault Cancer Registry   (France)

^r Isere's Cancer Registry   (France)

^s Lorraine Childhood Cancer Registry   (France)

^t Somme Cancer Registry   (France)

^u Rhone Alpes Childhood Registry   (France)

^v Tarn Cancer Registry   (France)

^w UNIVERSITÉ DE LYON   (France)

^x German Childhood Cancer Registry   (Germany)

^y Saarland Cancer Registry   (Germany)

^z Munich Cancer Registry   (Germany)

^aa ICELANDIC CANCER REGISTRY   (Iceland)

^ab Lombardy Cancer Registry ^*  (Ukraine)

^ac NATIONAL CANCER INSTITUTE   (Italy)

^ad Ferrara Cancer Registry   (Italy)

^ae Latina Cancer Registry   (Italy)

^af UNIVERSITY OF GENOA   (Italy)

^ag Macerata Cancer Registry Marche Childhood Cancer Registry   (Italy)

^ah MODENA CANCER REGISTRY   (Italy)

^ai Parma Cancer Registry ^*  (Italy)

^aj PARMA CANCER REGISTRY   (Italy)

^ak Piedmont Cancer Registry   (Italy)

^al Piedmont Childhood Cancer Registry   (Italy)

^am Ragusa Cancer Registry   (Italy)

^an Romagna Cancer Registry   (Italy)

^ao Sassari Cancer Registry   (Italy)

^ap Tuscan Cancer Registry   (Italy)

^aq Venetian Cancer Registry   (Italy)

^ar ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^as Malta National Cancer Registry   (Malta)

^at CANCER REGISTRY OF NORWAY   (Norway)

^au Southern Portugal Cancer Registry   (Portugal)

^av Cracow Cancer Registry   (Poland)

^aw National Cancer Registry of   (Slovakia)

^ax INSTITUTE OF ONCOLOGY   (Slovenia)

^ay Basque Country Cancer Registry   (Spain)

^az Granada Cancer Registry   (Spain)

^ba Mallorca Cancer Registry   (Spain)

^bb Murcia Cancer Registry   (Spain)

^bc Navarra Cancer Registry   (Spain)

^bd Tarragona Cancer Registry   (Spain)

^be Childhood Tumour Registry of Valencia   (Spain)

^bf National Childhood Cancer Registry and Instituto Lopez Pinero   (Spain)

^bg Cancer Registry of Sweden   (Sweden)

^bh LUND UNIVERSITY HOSPITAL   (Sweden)

^bi Cancer Registry of Basel   (Switzerland)

^bj GENEVA CANCER REGISTRY   (Switzerland)

^bk DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

^bl Cancer Center Amsterdam   (Netherlands)

^bm East Anglian Cancer Registry   (Ukraine)

^bn LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^bo Merseyside and Cheshire Cancer Registry   (Ukraine)

^bp Northern and Yorkshire Cancer Registry and Information Service   (Ukraine)

^bq Office for National Statistics   (Ukraine)

^br UNIVERSITY OF OXFORD   (United Kingdom)

^bs Childhood Cancer Research Group   (Ukraine)

^bt Thames Cancer Registry   (Ukraine)

^bu Trent Cancer Registry   (Ukraine)

^bv West Midlands Cancer Intelligence Unit   (Ukraine)

^bw Scottish Cancer Intelligence Unit   (Ukraine)

^bx Welsh Cancer Intelligence and Surveillance Unit   (Ukraine)

more..

Author keywords

Cervical cancer; Europe; Population based study; Survival; Trends

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MORPHOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; SQUAMOUS CELL CARCINOMA;

EID: 34248371599     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.01.048     Document Type: Article

References (29)

1. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 37 Suppl. 8 (2001) s4-s66
2. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P.M., et al. Carcinoma of the cervix uteri. In: Boyle P., La Vecchia C., and Walker A. (Eds). FIGO (Fédération Internationale de Gynécologie et d'Obstétrique). Annual Report on the Results of Treatment in Gynecological Cancer. J. Epidemiol. Biostat. 6 (2001) 7-43
3. Gatta G., Lasota M.B., and Verdecchia A. Survival of European women with gynaecological tumours during the period 1978-1989. Eur. J. Cancer 34 (1998) 2218-2225
4. In: Berrino F., Sant M., Verdecchia A., Capocaccia R., Hakulinen T., and Estève J. (Eds). Survival of cancer patients in Europe. The EUROCARE study. IARC Scientific Publications No. 132 vol. 132 (1995), IARC Lyon, France
5. Berrino F., Capocaccia R., Estève J., Gatta G., Hakulinen T., Micheli A., et al. Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific Publications vol. 151 (1999), IARC Lyon, France
6. In: Berrino F., Capocaccia R., Coleman M.P., Estève J., Gatta G., Hakulinen T., Micheli A., Sant M., and Verdecchia A. (Eds). Survival of cancer patients in Europe: the EUROCARE-3 Study. Ann. Oncol. vol. 14 (Suppl. 5) (2003) v1-v155
7. World Health Organisation. International classification of diseases for oncology. 3rd ed. (2000), WHO, Geneva, Switzerland
8. Esteban D, Whelan S, Laudico A, Parkin DM (eds). Manual for cancer registry personnel. IARC Technical Report No. 10. IARC Lyon, France, 1995.
9. Micheli A., Baili P., Mugno E., Queen M., Capocaccia R., Grosclaude P.C., and EUROCARE Working Group. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann. Oncol. 14 Suppl 5 (2003) v28-v40
10. Hakulinen T., and Abeywickrama K. A computer program package for relative survival analysis. Comp. Prog. Biomed. 19 (1987) 197-207
11. Smith P.G. Comparison between registries: age-standardized rates. In: Parkin D.M., Muir C.S., Whelan S.L., Gao Y.-T., Ferlay J., and Powell J. (Eds). Cancer incidence in five continents, volume V. IARC Scientific Publications No. 120 vol. 120 (1992), IARC Lyon, France 865-870
12. Coleman M.P., Gatta G., Verdecchia A., Estève J., Sant M., Storm H., et al., EUROCARE Working Group. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann. Oncol. 14 Suppl. 5 (2003) v128-v149
13. Bulk S., Visser O., Rozendaal L., Verheijen R.H., and Meijer C.J. Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br. J. Cancer 89 (2003) 834-839
14. Levi F., La Vecchia C., Randimbison L., and Te V.C. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991. Ann. Oncol. 8 (1994) 747-752
15. Bjorge T., Thoresen S.O., and Skare G.B. Incidence, survival and mortality in cervical cancer in Norway, 1956-1990. Eur. J. Cancer 29A (1993) 2291-2297
16. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10 (1994) 31-46
17. Sigurdsson K., Hrafnkelsson J., Geirsson G., Gudmundsson J., and Salvarsdottir A. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988. Gynecol. Oncol. 43 (1991) 64-70
18. Vercelli M., Capocaccia R., Quaglia A., Casella C., Puppo A., and Coebergh J.W. Relative survival in elderly European cancer patients: evidence for health care inequalities. Crit. Rev. Oncol. Hematol. 35 (2000) 161-179
19. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.B., et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?. Cancer 76 Suppl. 10 (1995) 1948-1955
20. Bielska-Lasota M., Krynicki R., Rabczenko D., Czerw-Gla{ogonek}b K., Starzewski J., Wronkowski Z., et al. Survival of cervical cancer patients in selected regions of Poland in 1990-1996, in relation to some prognostic factors. Prz. Epidemiol. 58 (2004) 523-536
21. Bielska-Lasota M. An analysis of 5-year survival of patients with cervical cancer treated with curable intent in relation to selected prognostic factors. A population-based study. Nowotwory J. Oncol. 55 (2005) 23-33
22. Anttila A., Ronco G., Clifford G., Bray F., Hakama M., Arbyn M., et al. Cervical cancer screening programmes and policies in 18 European countries. Br. J. Cancer 91 (2004) 935-941
23. Gericke C.A., and Busse R. Policies for disease prevention in Germany in the European context: a comparative analysis. J. Public Health 26 (2004) 230-238
24. van den Akker-van Marle M.E., van Ballegooijen M., van Oortmarssen G.J., Boer R., and Habbema J.D. Cost-effectiveness of cervical cancer screening: comparison of screening policies. J. Natl. Cancer Inst. 94 (2002) 193-204
25. Recommendations on cancer screening in the European Union, and Advisory Committee on Cancer Prevention. Eur. J. Cancer 36 (2000) 1473-1478
26. Saxën E., and Hakama M. Cancer illness in Finland with a note on the effects of age adjustment and early diagnosis. Ann. Med. Exp. Biol. Fenn. 42 Suppl. 2 (1964) 14-15
27. Sasieni P., and Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 357 (2001) 1490-1493
28. Bray F., Carstensen B., Møller H., Zappa M., Primic-Žakelj M., Lawrence G., et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2191-2199
29. Aareleid T., Pukkala E., Thomson H., and Hakama M. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur. J. Cancer 29A (1993) 745-749